Dealcast: The M&A Podcast

Dealcast is a fortnightly podcast from the Dealreporter and Activistmonitor teams covering M&A, ECM and activism. The Italian market is put under the microscope in this week's podcast. Dealreporter's Giulia Lasgni tells Julie-Anna Needham that improved sentiment is helping deal and ECM activity. Deane McRobie explains what is slowing down Creat Group's acquisition of Biotest. The US foreign investment committee CFIUS is taking a close look but why has its remit expanded?

The Dealreporter team looks at the Monsanto/Bayer merger reviews in the US and Europe. With Julie-Anna Needham, Francesca Micheletti and Joseph Tipograph

Dealcast is a fortnightly podcast from the Dealreporter and Activistmonitor teams covering M&A, ECM and activism. In this edition, the team discuss regulatory approval for the NXP and Qualcomm deal, and future options for Fiat Chrysler. With Julie-Anna Needham, Samantha Tomaszczyk and Deane McRobie.

Barclays potential separation of its investment bank and shareholder activism in Europe are discussed by the Dealreporter and Activistmonitor team

Dealcast: The Dealreporter team discuss Vantiv's bid for Worldpay and ECM activity in Europe, including Deutsche Bank, Allied Irish Bank, Santander, Delivery Hero, Just Eat and Saudi Aramco. With Julie-Anna Needham, Samantha Tomaszczyk and John West